Drug Type Unknown |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Phase 1 | FR | 07 Apr 2022 |
Not Applicable | - | EVE-EXE as second/third line and previous CDK 4/6i-containing treatment as first-line | (bbulavdtoj) = pjomuijpax qaroojmzto (usbitrktla ) | Negative | 17 Sep 2020 | ||
EVE-EXE as second/third line and no previous CDK 4/6i | (bbulavdtoj) = ulrmksvhph qaroojmzto (usbitrktla ) | ||||||
Not Applicable | 24 | BCPramIns | (gpgiiryzmy) = Hypoglycemia during dosing visit days were balanced between the three treatment groups (4-3-3) rtdqkhjamb (xnjmizxfid ) View more | - | 01 Jun 2019 | ||
PRAM+INS |